CV Sciences (CVSI) Gross Profit Growth (1y) (2014 - 2026)
CV Sciences (CVSI) Gross Profit Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -21.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.37% |
| Mar 31, 2026 | -5.79% |
| Dec 31, 2025 | -0.36% |
| Sep 30, 2025 | -11.19% |
| Jun 30, 2025 | -0.86% |
| Mar 31, 2025 | -10.52% |
| Dec 31, 2024 | -3.73% |
| Sep 30, 2024 | -3.53% |
| Jun 30, 2024 | 8.27% |
| Mar 31, 2024 | 3.98% |
| Dec 31, 2023 | 11.52% |
| Sep 30, 2023 | 17.99% |
| Jun 30, 2023 | 35.28% |
| Mar 31, 2023 | 54.15% |
| Dec 31, 2022 | -2.98% |
| Sep 30, 2022 | -33.76% |
| Jun 30, 2022 | -44.54% |
| Mar 31, 2022 | -50.98% |
| Dec 31, 2021 | -27.51% |
| Sep 30, 2021 | -4.07% |